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Abstract 
Background: A range of endophenotypes characterise psychosis, however there has been limited work 
understanding if and how they are inter-related.  
Methods: This multi-centre study includes 8754 participants: 2212 people with a psychotic disorder, 1487 
unaffected relatives of probands, and 5055 healthy controls. We investigated cognition [digit span (N=3127), 
block design (N=5491), and the Rey Auditory Verbal Learning Test (N=3543)], electrophysiology [P300 
amplitude and latency (N=1102)], and neuroanatomy [lateral ventricular volume (N=1721)]. We used linear 
regression to assess the interrelationships between endophenotypes.  
Results: The P300 amplitude and latency were not associated (regression coef. -0.06, 95% CI -0.12–0.01, 
p=0.060), and P300 amplitude was positively associated with block design (coef. 0.19, 95% CI 0.10–0.28, 
p<0.001). There was no evidence of associations between lateral ventricular volume and the other measures 
(all p>0.38). All the cognitive endophenotypes were associated with each other in the expected directions 
(all p<0.001). Lastly, the relationships between pairs of endophenotypes were consistent in all three 
participant groups, differing for some of the cognitive pairings only in the strengths of the relationships. 
Conclusions:  The P300 amplitude and latency are independent endophenotypes; the former indexing spatial 
visualisation and working memory, and the latter is hypothesised to index basic processing speed. 
Individuals with psychotic illnesses, their unaffected relatives, and healthy controls all show similar patterns 
of associations between endophenotypes, endorsing the theory of a continuum of psychosis liability across 
the population. 
Keywords:  
Schizophrenia; Unaffected relatives; P300; Working memory; Verbal memory; Lateral ventricular volume  
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Introduction 
Psychotic disorders, including schizophrenia and bipolar disorder, have considerable heritability with 
estimates ranging between 60-85% (Cardno et al. 1999; Smoller & Finn 2003; Sullivan et al. 2012), and there 
is evidence of significant genetic overlap between these disorders (Lee et al. 2013). Psychoses are complex 
genetic disorders where many common variants contribute small increments of risk, and rare variants 
contribute greater risks (Gratten et al. 2014; Geschwind & Flint 2015). While many common loci and some 
rare variants have now been identified (Xu et al. 2008; Stefansson et al. 2008; Stone et al. 2008; Walsh et al. 
2008; Purcell et al. 2009; Grozeva et al. 2011; Sklar et al. 2011; Lee et al. 2013; Ripke et al. 2013, 2014; Green 
et al. 2015), little is known about their functional roles and the mechanisms through which they lead to the 
disease (Geschwind & Flint 2015; Harrison 2015). 
Endophenotypes could help us gain a better understanding of the underlying neurobiology (Gottesman & 
Gould 2003; Cannon & Keller 2006; Gur et al. 2007). These are biological markers which are heritable, co-
segregate with a disorder within families, are observed in unaffected family members at a higher rate than in 
the general population, and are expressed in an individual whether or not the illness is active (Gottesman & 
Gould 2003). Endophenotypes could thus be used to better understand the mechanisms underlying the 
associations between genetic variants and the disorder (Hall & Smoller 2010; Braff 2015). 
Although there is an extensive literature identifying and validating endophenotypes for psychosis, fewer 
studies have examined the relationships between different endophenotypes. Studies conducted so far have 
mainly analysed the associations between different cognitive measures (Toomey et al. 1998; Dickinson et al. 
2002, 2006; Sullivan et al. 2003; Gladsjo et al. 2004; Sheffield et al. 2014; Seidman et al. 2015), but there is a 
lack of literature examining brain structural–cognitive and electrophysiological–cognitive pairings. Moreover, 
the inclusion of unaffected relatives in these studies has been rare, yet examining relatives – who carry 
increased genetic risk but have no illness or treatment confounding factors – is crucial for establishing the 
utility of these markers for genetic research. 
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This study seeks to investigate the relationships between the following electrophysiological, neurocognitive, 
and neuroanatomical endophenotypes for psychosis: 
 P300 event-related potential: Reduced amplitude and prolonged latency of the P300 wave have 
consistently been found in patients with psychotic illnesses as well as in unaffected relatives, 
compared to controls (Blackwood et al. 1991; Weisbrod et al. 1999; Pierson et al. 2000; Winterer et al. 
2003; Bramon et al. 2005; Price et al. 2006; Schulze et al. 2008; Bestelmeyer et al. 2009; Díez et al. 
2013; Light et al. 2015; Turetsky et al. 2015). The P300 amplitude is thought to be a correlate of 
attention and working memory (Näätänen 1990; Ford 2014). Although the latency has been less 
precisely characterized, it is thought to index classification speed (Polich 2007, 2011).  
 Cognitive performance: Deficits on cognitive tests such as digit span (measuring working memory), 
block design (measuring working memory and spatial visualisation), and the Rey Auditory Verbal 
Learning Task (RAVLT) immediate and delayed recall (measuring short and long term verbal memory, 
respectively) are common and persistent across psychotic disorders (Heinrichs & Zakzanis 1998; Gur et 
al. 2007; Bora et al. 2009; Stone et al. 2011; Bora & Pantelis 2015; Kim et al. 2015b; Lee et al. 2015). 
Abnormalities are often observed before the onset of the illness as well as in unaffected relatives 
(Glahn et al. 2006; Saperstein et al. 2006; Snitz et al. 2006; Birkett et al. 2008; Horan et al. 2008; 
Forbes et al. 2009; Reichenberg et al. 2010; Ivleva et al. 2012; Park & Gooding 2014; Gur et al. 2015). 
 Lateral Ventricular Volume: Increased ventricular volume is a highly replicated finding in patients with 
psychosis compared to controls (Sharma et al. 1998; Wright et al. 2000; Fannon et al. 2000; Shenton 
et al. 2001; McDonald et al. 2002, 2006; Strasser et al. 2005; Boos et al. 2007; Crespo-Facorro et al. 
2009; Kempton et al. 2010; Fusar-Poli et al. 2013; Haijma et al. 2013; Kumra et al. 2014). This 
enlargement has been attributed to neurodevelopmental difficulties, disease progression, and/or the 
effects of antipsychotic medications (Pilowsky et al. 1993; Gogtay et al. 2003; McDonald et al. 2006). 
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This multi-centre study, seeking to investigate the relationships between multi-modal endophenotypes, 
includes the largest sample yet of individuals with psychosis, their unaffected first-degree relatives, and 
controls. The main objective is to facilitate the use of endophenotypes for genetic research into psychosis, 
which requires well defined and characterised measures. The aim of this study was therefore to examine the 
relationships between different endophenotype pairs, and in particular, to characterise the P300 event 
related potential in the context of well-defined cognitive markers. 
Methods and Materials 
Sample and clinical assessments 
The total sample included 8754 participants: 2212 individuals with a diagnosis of a psychotic disorder (see 
Table 1 for a breakdown of diagnoses), 1487 of their unaffected first-degree relatives (with no personal 
history of psychosis), and 5055 healthy controls (with no personal or family history of psychosis). Relatives 
and controls were not excluded if they had a personal history of non-psychotic disorders (such as depression 
or anxiety), provided they were well and off psychotropic medication at the time of testing and for the 
preceding 12 months.  
To confirm or rule out a DSM-IV (APA 1994) diagnosis, all participants underwent a structured clinical 
interview with either the Comprehensive Assessment of Symptoms and History (Andreasen et al. 1992), the 
Structured Clinical Interview for DSM Disorders (Spitzer et al. 1992), the Schedule for Affective Disorders and 
Schizophrenia (Endicott & Spitzer 1978) or the Schedule for Clinical Assessment in Neuropsychiatry, Version 
2.0 (Wing et al. 1990). Participants were excluded if they had a history of neurologic disease or a loss of 
consciousness due to a head injury.  
Recruitment took place across 11 locations in Australia and Europe (Germany, Holland, Spain, and the United 
Kingdom) (see Table S1 in the supplement). Participants provided written informed consent, and the study 
was approved by the respective ethical committees at each of the 11 participating centres. 
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The main focus of this paper is an analysis of the associations between different endophenotype domains, 
which represents new and unpublished data. Some centres have previously published comparisons in 
endophenotype performance between groups (patients, relatives and controls) (Weisbrod et al. 1999; Steel 
et al. 2002; Hulshoff Pol et al. 2002; McDonald et al. 2002; Bramon et al. 2005; Johnstone et al. 2005; Hall et 
al. 2006b; Price et al. 2006; Schulze et al. 2006; González-Blanch et al. 2007; Waters et al. 2009; Wobrock et 
al. 2009; Crespo-Facorro et al. 2009; Toulopoulou et al. 2010; Collip et al. 2013). Here we also present results 
of a mega-analysis of the combined multi-centre sample. 
Neuropsychological assessments 
The Wechsler Adult Intelligence Scale, revised version (Wechsler 1981) or third edition (Wechsler 1997), 
were administered to participants. Performance on two subtests was used for analyses: the combined 
forward and backward digit span (measuring attention and working memory) and block design (measuring 
spatial visualisation). The Rey Auditory Verbal Learning Test (Rey 1964), including both immediate and 
delayed recall (assessing short- and long-term verbal memory, respectively), was also administered. Higher 
scores on the cognitive tasks indicate better performance. Full methodology for each contributing site is 
reported elsewhere (Johnstone et al. 2005; Crespo-Facorro et al. 2007; González-Blanch et al. 2007; Waters 
et al. 2009; Toulopoulou et al. 2010; Walters et al. 2010; Korver et al. 2012). 
EEG data collection and processing 
Electrophysiological data were obtained from three sites (Table S1). EEG data acquisition and processing 
methods varied slightly between sites as summarised below. The full methods for each site are reported 
elsewhere (Weisbrod et al. 1999; Bramon et al. 2005; Hall et al. 2006b; Price et al. 2006; Waters et al. 2009). 
In summary, EEG was collected from 17 to 20 electrodes placed according to the International 10/20 system 
(Jasper 1958). The P300 event related potential was obtained using a standard two-tone frequency deviant 
auditory oddball paradigm, with standard (‘non target’) tones of 1000Hz and rare (‘target’) tones of 1500Hz. 
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The number of tones presented varied from 150 to 800, the tones were 80dB or 97dB, lasted for 20-50ms, 
and the inter-stimulus interval was between 1 and 2 seconds. The majority of participants (93.4%) were 
asked to press a button in response to ‘target’ stimuli, but a subset were asked to close their eyes and count 
‘target’ stimuli in their head.  
The data were continuously recorded in one of three ways: 500Hz sampling rate and 0.03-120Hz band pass 
filter; 200Hz sampling rate and 0.05-30Hz band pass filter; or 400Hz sampling rate and 70Hz low-pass filter. 
Linked earlobes or mastoids were used as reference and vertical, and in most cases also horizontal, electro-
oculographs were recorded at each site and used to correct for eye-blink artefacts using regression based 
weighting coefficients (Semlitsch et al. 1986). After additional manual checks, artefact-free epochs were 
included and baseline corrected before averaging. The averaged waveforms to correctly detected targets 
were then filtered using 0.03 or 0.05 Hz high-pass and 30 or 45 Hz low-pass filters. The peak amplitude and 
latency of the P300 were measured at electrode location PZ (parietal midline), within the range of 250-
550ms post-stimulus. 
MRI data collection and processing 
MRI data acquisition and image processing varied between sites; see previous publications and the 
supplementary materials for an outline of the methods used for each centre (Barta et al. 1997; Frangou et al. 
1997; Hulshoff Pol et al. 2002; McDonald et al. 2002, 2006, McIntosh et al. 2004, 2005a, 2005b; Schulze et 
al. 2006; Wobrock et al. 2009; Crespo-Facorro et al. 2009; Dutt et al. 2009; Mata et al. 2009; Habets et al. 
2011; Collip et al. 2013)Field strengths included 1, 1.5 or 3 Tesla. Lateral ventricular volumes were measured 
using automatic or semi-automatic region of interest analyses, and included the body, frontal, occipital and 
temporal horns. 
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Statistical methods 
Mega-analysis of group comparisons: Endophenotype measures were first standardised for each site 
separately using the mean and standard deviation within each site. Linear regression analyses for each 
measure were used to establish whether endophenotype performance differed according to group (patients, 
relatives, and controls). The outcome in each regression model was the endophenotype measure and the 
main predictor was group. These analyses were adjusted for age, gender, clinical group, study site and, 
where significant, group by site interactions. 
Associations between endophenotypes: Linear regression models were used to investigate associations 
between each pair of endophenotypes. Potential effect modification by group membership was assessed by 
specifying in the statistical model a term for the interaction between the predictor of the endophenotype 
pair and group (patient, relative, control). Where we found evidence that the relationship between a pair of 
endophenotypes differed according to group, associations are reported separately for patients, relatives and 
controls.  Where there was no evidence of effect modification, the interaction term was dropped from the 
model, and associations are reported for the whole sample adjusted for group. These analyses were 
adjusted for age, gender, clinical group and study site.  
In all analyses, we accounted for correlations between individuals within families using robust standard 
errors. 63% of the participants had no other family member taking part, but the study also included 1056 
families of 2-11 members each (85% of the families had only two members included in the sample). This 
family clustering violates the independence of observations assumption in linear regression. To account for 
this clustered structure in the dataset we created a new variable “family ID” that was shared by all 
individuals in each family. Then we used the variance estimator with the robust cluster option in all the 
linear regression models. This allowed us to account for the within-family correlations and maintain correct 
type-1 error rates. This is a standard approach in family studies (Bramon et al, 2014; Ranlund et al., 2014; 
Shaikh et al., 2013). 
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We examined the distribution of residuals and plots of residuals versus fitted values for all models and were 
able to rule out departures from normality and heteroscedasticity. Lateral ventricular volume showed a 
positively skewed distribution and to account for this we used bootstrap methods for analyses where this is 
the outcome variable. Heteroscedasticity was not found to be a concern for ventricular volumes. P values 
are not presented for the models which used bootstrapping; instead, we examined the 95% bias-corrected 
confidence intervals to check for statistical significance at the 5% level (p=0.05). 
Although we tested 7 endophenotypes, we expect measurements within domains to be correlated and thus 
a correction of p-values by 7 tests through Bonferroni or other methods was deemed too stringent for a 
hypothesis-driven study such as this (Rothman 1990; Savitz & Olshan 1995; Perneger 1998). We therefore 
corrected for associations between 3 domains (EEG, MRI, cognition), with a corrected significance threshold 
of 0.05/3 = 0.0167, that we rounded to the slightly more stringent cut-off of p<0.01. Statistical analyses were 
conducted using STATA version 13.  
Results 
Sample characteristics 
The sample characteristics are summarised in Table 1. Patients were on average 12.4 years younger than 
relatives (95% CI: 11.4 to 13.4; p<0.001) and 11.9 years younger than controls (95% CI: 11.1 to 12.7; 
p<0.001).  There was no evidence of any age difference between relatives and controls.  There was a lower 
proportion of females than males among patients than among relatives and controls (32.1%, 58.0% and 
51.5% respectively; global p<0.001).  
Group comparisons on endophenotype performance 
As shown in Figure 1 and Table 2, differences between the three participant groups on the endophenotypes 
followed the expected pattern with performance improving from patients through to relatives and controls. 
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We found evidence that patients’ scores differed significantly from those of controls with smaller P300 
amplitudes, delayed P300 latency, larger lateral ventricular volumes and deficits in digit span, block design 
and RVLT immediate recall. When compared to controls, the unaffected relatives showed reduced P300 
amplitude, delayed P300 latency and poorer performance in digit span and block design. 
Associations between endophenotype pairs 
Associations which do not differ according to clinical group 
Associations between endophenotype pairs where there was no evidence of effect modification by group 
are reported in Table 3. There was no evidence of an association between the P300 amplitude and latency at 
the 1% level of statistical significance (coef. -0.06, 95% CI -0.12 to 0.01, p=0.06). The P300 amplitude was 
positively associated with digit span (coef. 0.15, 95% CI 0.04 to 0.26, p=0.009) and block design (coef. 0.19, 
95% CI 0.10 to 0.28, p<0.001) performances, but not with either of the RAVLT measures. The P300 latency 
showed weak evidence of a negative association with digit span (coef. -0.15, 95& CI -0.28 to -0.03, p=0.017). 
Lateral ventricular volume showed no evidence of an association with any of the other measures. All 
cognitive pairings were significantly positively associated (all p<0.001).  
Associations which differ according to clinical group 
For three pairs of cognitive endophenotypes, we found evidence of an interaction with group. This indicates 
that the association between these endophenotype pairs differs between patients, relatives and controls, as 
reported in Figure 2 (and Table S3 in the Supplement). In all three cases, the relationship between 
endophenotype pairs was in the same direction for the three groups, differing only in magnitude.  
There was strong evidence that digit span and RAVLT immediate and delayed recall were positively 
associated with scores on the block design task in all three groups (patients, relatives and controls). The 
magnitude of each association was greater among patients than controls (all p<0.01), but there was no 
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evidence that the strength of the relationship among relatives was different from that among controls (all 
p>0.03). See supplementary Table S3 for full results.  
Discussion 
This study examined the relationships between different multi-modal psychosis endophenotypes in a large 
multi-centre sample of patients, their unaffected first-degree relatives, and controls.  
Our mega-analysis confirms that both patients and relatives showed reduced amplitudes and prolonged 
latencies of the P300, compared to controls, replicating past findings and providing further evidence that 
these are  endophenotypes for psychosis (Turetsky et al. 2000; Bramon et al. 2005; Price et al. 2006; Schulze 
et al. 2008; Thaker 2008; Bestelmeyer et al. 2009; Díez et al. 2013). We found no evidence of association 
between the P300 amplitude and latency, indicating that these are independent measures. To examine 
whether variability on P300 amplitude and latency could potentially affect the correlations between these, 
we tested for heteroscedasticity between clinical groups. The standard deviations between the patient, 
relative and control groups did not vary significantly and are thus unlikely to explain the lack of correlation 
between P300 amplitude and latency performance. In contrast to our results, Hall et al (Hall et al. 2006a) 
and Polich and colleagues (Polich 1992; Polich et al. 1997) found a negative correlation between the 
amplitude and latency. Notably however, these past studies included only small samples (up to 128 
participants) compared to our study (N=1083), and they did not take into account covariates such as age and 
gender that are known to influence both P300 parameters (Goodin et al. 1978; Polich et al. 1985; Conroy & 
Polich 2007; Chen et al. 2013). Furthermore, in the studies by Polich et al (Polich 1992; Polich et al. 1997) the 
amplitude – latency correlation was strongest over frontal electrodes, and not parietal as investigated in our 
current study. More recently, Hall et al (Hall et al. 2014) found a negative correlation between the amplitude 
and latency in a sample of 274 patients with psychosis and controls after controlling for age and gender 
effects. Further research is thus needed to clarify the relationship between the P300 amplitude and latency. 
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However, our findings in this large sample suggest that the measures are independent, indexing separate 
brain functions.  
We found associations between the P300 amplitude and both digit span and block design, as in previous 
smaller studies (Souza et al. 1995; Polich et al. 1997; Fjell & Walhovd 2001; Hermens et al. 2010; Kaur et al. 
2011; Dong et al. 2015b). According to the context-updating theory (Heslenfeld 2003; Kujala & Naatanen 
2003), the P300 amplitude is an attention-driven, context-updating mechanism, which subsequently feeds 
into memory stores (Polich 2007, 2011). Hence, one would expect the amplitude to be associated with 
cognitive tasks that require attention and working memory, such as digit span and block design (Näätänen 
1990; Baddeley 1992; Ford 2014). The context-updating theory provides a possible explanation for the 
association between P300 amplitude and block design, since this task requires a constant update of the 
mental representation of the blocks, in order to complete the target pattern (Polich 2007, 2011). The lack of 
evidence for associations between P300 amplitude and the RAVLT tests support the idea that the 
neurobiology of verbal memory is distinct from the attentional and working memory processes linked to the 
P300 amplitude (Polich 2011). 
The P300 latency showed evidence of a trend-level association with digit span, and no evidence of an 
association with the other measures. Previous studies have provided conflicting results, with some reporting 
associations with attention and working memory (Polich et al. 1983), while others have not (Fjell & Walhovd 
2001; Walhovd & Fjell 2003; Dong et al. 2015b). The P300 latency has been conceptualised as a measure of 
classification speed (Polich 2011; van Dinteren et al. 2014). Investigating the relationship between 
behavioural reaction times (i.e. the speed of button press in the task) and the P300 latency, some have 
found associations (Bashore et al. 2014) while others have not (Ramchurn et al. 2014). Furthermore, there is 
a substantial body of research showing that the P300 latency as well as reaction times increase (that is they 
slow down) with ageing in healthy participants (Polich 1996; Chen et al. 2013). Based on our findings we 
hypothesise that the P300 latency is a specific measure of processing speed at a basic neuronal level. In 
contrast, block design and the RAVLT task – while influenced by processing speed – reflect wider cognition 
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including spatial abilities and verbal memory. The more complex elements to these tasks may therefore 
obscure effects of a simple processing speed, and hence explain the lack of association with P300 latency. 
The trend-level association with digit span performance – a task dependent on attention and short-term 
working memory – is in line with this interpretation too.  
In terms of lateral ventricular volume, there was no evidence of a relationship with any other 
endophenotype investigated. Enlargement of cerebral ventricles remains the best replicated biological 
marker in schizophrenia and bipolar disorder, according to several meta-analyses (Kempton et al. 2010; 
Olabi et al. 2011; De Peri et al. 2012; Fusar-Poli et al. 2013; Fraguas et al. 2016; van Erp et al. 2016; 
Huhtaniska et al. 2017; Moberget et al. 2017). Our hypothesis that ventricular volumes would correlate with 
other endophenotypes of a functional nature was not confirmed by our data. Of course for such analyses our 
sample size was modest ranging 428 to 1001 and lack of statistical power could be a potential reason. Keilp 
et al (Keilp et al. 1988) found an association with verbal memory and others have found enlarged lateral 
ventricles to be associated with poorer motor speed (Antonova et al. 2004; Hartberg et al. 2011; Dong et al. 
2015a). A limitation of our study is the heterogeneity of the MRI methodology between study sites, which 
might have obscured any true associations. We conclude that ventricular volumes do not seem to exert a 
detectable influence on brain function in terms of cognition or cortical neurophysiology, however 
association studies of structural-functional biomarkers in larger samples are needed. 
 
With regards to group comparisons, although patients showed enlarged lateral ventricles compared to 
controls, a very well supported finding (Wright et al. 2000; Steen et al. 2006; Cahn et al. 2009; Kempton et 
al. 2010), having adjusted by age and sex we observed no volume differences between relatives and 
controls. This is consistent with the latest meta-analysis of brain structure in relatives of patients with 
schizophrenia (Boos et al. 2007), and suggests that enlarged ventricles in patients are less heritable than 
previously thought. Instead, they might be related to illness progression, or to environmental effects or 
antipsychotic medication, as seen in both animal models of antipsychotic exposure (Dorph-Petersen et al. 
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2005; Konopaske et al. 2007), and in human studies (Ho et al. 2011; Fusar-Poli et al. 2013; Van Haren et al. 
2013).  
For all cognitive measures, patients performed less well than controls, consistent with extensive literature 
(Ayres et al. 2007; Horan et al. 2008; Bora et al. 2010, 2014; Fusar-Poli et al. 2012; Bora & Murray 2014; 
Fatouros-Bergman et al. 2014; Stone et al. 2015). For the digit span and block design, there were also 
statistically significant differences between relatives and controls, suggesting a possible effect of increased 
genetic risk for psychosis. However, this was not seen for the immediate or delayed recall of the RAVLT task, 
where controls and relatives had similar performance. While some have reported verbal memory 
impairments in relatives of patients (Sitskoorn et al. 2004; Wittorf et al. 2004; Massuda et al. 2013), other 
studies have not (Üçok et al. 2013; Kim et al. 2015a). These findings suggest that working memory and 
spatial visualisation might represent more promising endophenotypes for genetic research into psychosis 
than verbal memory.  
The associations between pairs of cognitive measures were strong and in the expected directions, as per 
previous findings (Dickinson et al. 2002; Sullivan et al. 2003; Gladsjo et al. 2004; Sheffield et al. 2014; 
Seidman et al. 2015). It is interesting to note that for some cognitive measures, the relationships interacted 
with group; however, the direction of the effect remained the same across patients, relatives and controls. 
The interaction effects with group were found exclusively amongst the cognitive measures, and not in any of 
the other domains. This is possibly due to the larger sample sizes for the cognitive measures, yielding greater 
statistical power and enabling the detection of subtle interaction effects. 
Both the lack of interaction effects for most associations investigated, and the gradient effects identified 
(where there was an interaction), are consistent with the notion that endophenotype impairments 
characterising psychosis represent a continuum that includes both relatives and the general population. 
Ultimately this continuum reflects the underlying variation in genetic liability of developing the disease 
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(Johns & van Os 2001; Wiles et al. 2006; Allardyce et al. 2007; Esterberg & Compton 2009; Ian et al. 2010; 
DeRosse & Karlsgodt 2015).  
This study has several limitations: Firstly, association analyses could only be done for those participants with 
data available for pairs of endophenotypes and this led to relatively smaller samples for some of the 
associations. Secondly, there was a mismatch in age and gender between patients and relatives. The group 
of relatives has older individuals and more females compared to the group of patients who are younger and 
include more males. This is a common occurrence in psychosis family studies because the onset of psychosis 
in typically in youth. Most of the families who participated in the study include unaffected parents (with 
greater participation of mothers) and their affected and unaffected offspring. Family studies in psychosis are 
less likely to recruit affected parents. Because of this, we recruited a control group with a wider age range 
than either the other groups and with a balanced gender distribution so as to improve the age and sex 
matching across the two key comparisons (controls versus patients, controls versus relatives). Furthermore, 
since age and sex remains a potential confounder, we included age and sex as co-variates in the models 
throughout the study. As shown in Table S4 in the supplement, there was no evidence of model instability 
based on the estimates and confidence interval width between the models with and without age and sex. 
Another limitation of this study is that we were unable to account for potential moderators such as tobacco, 
other drug use and medication. Also, information about participants’ socioeconomic status was not 
available.  These clinical and demographic variables could have a potentially important influence on how the 
three clinical groups perform on endophenotypes. However, the main analyses, which was to investigate 
associations between endophenotypes are all done within-individuals and are thus less likely to be 
influenced by exposure to drugs and medication. As for clinical variables such as depression, the sample 
included 5.5% of individuals with a history of depression. Depression did not constitute an exclusion criterion 
for our study because it is such a prevalent disorder that if excluded it would probably make our findings 
hard to generalize. We have re-analyzed the group comparisons excluding all participants with a history of 
depression and the overall findings are unchanged.  
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A further potential limitation was the heterogeneity of methods between study sites; differences in cognitive 
test versions and variation on the EEG and MRI protocols all introduced greater variability into the data. All 
measures were standardised within centres to minimise this variability.  Despite this challenge, it is precisely 
through this multi-centre effort that we were able to achieve a very large sample, the key strength of this 
study. As the Psychiatric Genomics Consortium’s work shows, large international collaborations are essential 
in genetic studies of common diseases and traits (Sklar et al. 2011; Lee et al. 2013; Smoller et al. 2013; Ripke 
et al. 2014). A further strength of this study is the use of regression models as opposed to the correlation 
approach frequently seen in the literature (Brewer et al. 1970; Polich et al. 1983, 1997; Breteler et al. 1994; 
Brillinger 2001; Kim et al. 2003), which allowed us to account for somme important confounding factors, 
such as ageing effects. Not only did this approach reduce vulnerability to spurious correlations, but it 
allowed the examination of interesting interaction effects across groups. 
In summary, this study has investigated the relationships between endophenotypes for psychosis, including 
measures of cognition, electrophysiology, and brain structure. We have shown that cognitive measures are 
associated with each other as expected, and we have provided support for the notion that the amplitude 
and latency of the P300 are independent endophenotypes. The P300 amplitude is an index of spatial 
visualisation and working memory, while the latency is hypothesised to be a correlate of basic speed of 
processing. Individuals with psychotic illnesses, their unaffected relatives, and healthy controls all have 
similar patterns of associations between all pairs of endophenotypes, endorsing the theory of a continuum 
of liability of developing psychosis across the population. 
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Figure 1. Estimated marginal means (adjusted for average age, gender, and study site) of standardised endophenotype scores by group 
(patients, relatives, and controls). Error bars represent standard errors of the means. RAVLT = Rey Auditory Verbal Learning Task. 
Figure 2. Interactions between group (patient, relative and control) and endophenotype pairs (standardised scores). Graphs are adjusted 
for covariates (age, gender and study site), and include 95% confidence intervals. RAVLT = Rey Auditory Verbal Learning Task.  
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Sample size, N (%) 2212 (25.3%) 1487 (17.0%) 5055 (57.7%) 8754 
Age, mean years (SD)† 33.6 (10.6) 46.0 (15.8) 45.5 (16.2) 42.6 (15.8) 
Age range (years) 16 – 79 16 – 85 16 – 89 16 – 89 
Gender (% female)† 32.1% 58.0% 51.5% 47.7% 
Diagnoses; N (%) 
    
Schizophrenia 1396 (63.1%) - - 1396 (15.9%) 
Bipolar I Disorder 135 (6.1%) - - 135 (1.5%) 
Psychosis NOS 168 (7.6%) - - 168 (1.9%) 
Schizophreniform Disorder 158 (7.1%) - - 158 (1.8%) 
Schizoaffective Disorder 124 (5.6%) - - 124 (1.4%) 
Brief Psychotic Disorder 56 (2.5%) - - 56 (0.6%) 
Other psychotic illness 175 (7.9%) - - 175 (2.0%) 
Depression 
 
246 (16.5%) 232 (4.6%) 478 (5.5%) 
Anxiety 
 
47 (3.2%) 24 (0.5%) 71 (0.8%) 
Other non-psychotic illness 
 
62 (4.2%) 106 (2.1%) 168 (1.9%) 
No psychiatric illness 
 
1132 (76.1%) 4693 (92.8%) 5825 (66.5 %) 
Endophenotypes  N=sample size, Mean (SD) of raw scores unadjusted for covariates 






























Block Design  









Digit Span  









RAVLT immediate recall  









RAVLT delayed recall 









SD = Standard deviation; NOS = Not otherwise specified; RAVLT = Rey Auditory Verbal Learning Task; † Missing data for 
age (717 subjects) and gender (6 subjects). The group differences in endophenotype performance adjusted by 
covariates are reported in table 2. 
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P300 amplitude  < 0.001 
-0.50 
(-0.71 to -0.29)  
p < 0.001 
-0.16  
(-0.32 to -0.01)  
p = 0.061 
-0.34 
(-0.54 to -0.14)  
p = 0.001 
P300 latency   < 0.001 
0.47 
(0.33 to 0.61)  
p < 0.001 
0.03 
(-0.14 to 0.19)  
p = 0.749 
0.44 
(0.29 to 0.60)  
p < 0.001 
Lateral Ventricular 
Volume   
0.20 
(0.08 to 0.32)  
0.09  
(-0.06 to 0.23) 
0.11  
(-0.04 to 0.25)  
Digit Span  < 0.001 
-0.72  
(-0.88 to -0.55)  
p < 0.001 
-0.14  
(-0.32 to 0.05)  
p = 0.141 
-0.58  
(-0.77 to -0.39)  
p < 0.001 
Block Design  < 0.001 
-0.91  
(-1.07 to -0.75)  
p < 0.001 
-0.08  
(-0.21 to 0.04)  
p = 0.190 
-0.83  
(-0.97 to -0.69)  





( -2.29 to -0.37)  
p = 0.007 
-1.24  
(-2.22 to -0.27)  
p = 0.012 
-0.08 
(-0.24 to 0.07)  





( -2.21 to 0.25)  
p =0.118 
-0.94  
(-2.18 to 0.30)  
p =0.136 
-0.03  
(-0.20 to 0.13)  
p = 0.669 
Linear regression models investigating group differences on endophenotype performance. Endophenotype data were 
standardised for each site using the mean and standard deviation within each site. The main predictor was clinical 
group (patients, relatives and controls). All models included age, gender, study site and, where significant, group by 
centre interactions. We used robust standard errors to account for correlations within families in all models. 
* p-value for the overall test of a group effect; Note that P values were not produced for the models that include lateral 
ventricular volume since we used bootstrapping, which is a percentile based method; therefore we looked at the bias-
corrected confidence intervals to check for significance. 
RAVLT = Rey Auditory Verbal Learning Task; CI = Confidence Interval. 
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(-0.12 to 0.01) 
p = 0.060 
N=428 
0.05 




(0.04 to 0.26) 
p = 0.009 
N=426 
0.19 
(0.10 to 0.28) 
p < 0.001 
N=255 
0.11 
(-0.02 to 0.25) 
p = 0.102 
N=255 
0.08 
(-0.06 to 0.22) 










(-0.28 to -0.03) 
p = 0.017 
N=437 
-0.04 
(-0.12 to 0.04) 
p = 0.333 
N=254 
0.03 
(-0.09 to 0.15) 
p = 0.699 
N=254 
0.03 
(-0.07 to 0.14) 



























(0.30 to 0.36) 
p < 0.001 
N=291 
0.39 
(0.28 to 0.49) 
p < 0.001 
N=291 
0.31 
(0.20 to 0.42) 
p < 0.001 
Block 
Design 
   - 
N=2169 
0.26 
(0.21 to 0.30) 
p < 0.001 
N=2137 
0.24 
(0.20 to 0.29) 




    - 
N=3505 
0.76 
(0.74 to 0.78) 
p < 0.001 
RAVLT = Rey Auditory Verbal Learning Task. 
Regression models using standardised scores, adjusted for age, gender, study site and group using robust standard 
errors to account for correlations within families and, where significant, group by centre interactions.  
Statistics reported are sample sizes, regression coefficients (95% confidence intervals), and p-values. Note that P values 
were not produced for the models that include lateral ventricular volume since we used bootstrapping, which is a 
percentile based method; therefore we looked at the bias-corrected confidence intervals to check for significance. 
 
